BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 22815483)

  • 1. The p21-activated kinase PAK3 forms heterodimers with PAK1 in brain implementing trans-regulation of PAK3 activity.
    Combeau G; Kreis P; Domenichini F; Amar M; Fossier P; Rousseau V; Barnier JV
    J Biol Chem; 2012 Aug; 287(36):30084-96. PubMed ID: 22815483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct, but compensatory roles of PAK1 and PAK3 in spine morphogenesis.
    Boda B; Jourdain L; Muller D
    Hippocampus; 2008; 18(9):857-61. PubMed ID: 18481281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of synaptic network dynamics by the intellectual disability protein PAK3.
    Dubos A; Combeau G; Bernardinelli Y; Barnier JV; Hartley O; Gaertner H; Boda B; Muller D
    J Neurosci; 2012 Jan; 32(2):519-27. PubMed ID: 22238087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The four mammalian splice variants encoded by the p21-activated kinase 3 gene have different biological properties.
    Kreis P; Rousseau V; Thévenot E; Combeau G; Barnier JV
    J Neurochem; 2008 Aug; 106(3):1184-97. PubMed ID: 18507705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel PAK1 variant causative of neurodevelopmental disorder with postnatal macrocephaly.
    Ohori S; Mitsuhashi S; Ben-Haim R; Heyman E; Sengoku T; Ogata K; Matsumoto N
    J Hum Genet; 2020 May; 65(5):481-485. PubMed ID: 32005903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p21-Activated kinase 3 (PAK3) protein regulates synaptic transmission through its interaction with the Nck2/Grb4 protein adaptor.
    Thévenot E; Moreau AW; Rousseau V; Combeau G; Domenichini F; Jacquet C; Goupille O; Amar M; Kreis P; Fossier P; Barnier JV
    J Biol Chem; 2011 Nov; 286(46):40044-59. PubMed ID: 21949127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PAK3 mutations responsible for severe intellectual disability and callosal agenesis inhibit cell migration.
    Duarte K; Heide S; Poëa-Guyon S; Rousseau V; Depienne C; Rastetter A; Nava C; Attié-Bitach T; Razavi F; Martinovic J; Moutard ML; Cherfils J; Mignot C; Héron D; Barnier JV
    Neurobiol Dis; 2020 Mar; 136():104709. PubMed ID: 31843706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p21-Activated kinases 1 and 3 control brain size through coordinating neuronal complexity and synaptic properties.
    Huang W; Zhou Z; Asrar S; Henkelman M; Xie W; Jia Z
    Mol Cell Biol; 2011 Feb; 31(3):388-403. PubMed ID: 21115725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p21-Activated kinase 3 promotes cancer stem cell phenotypes through activating the Akt-GSK3β-β-catenin signaling pathway in pancreatic cancer cells.
    Wu HY; Yang MC; Ding LY; Chen CS; Chu PC
    Cancer Lett; 2019 Aug; 456():13-22. PubMed ID: 31051214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The p21-activated kinase 3 implicated in mental retardation regulates spine morphogenesis through a Cdc42-dependent pathway.
    Kreis P; Thévenot E; Rousseau V; Boda B; Muller D; Barnier JV
    J Biol Chem; 2007 Jul; 282(29):21497-506. PubMed ID: 17537723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A de novo mutation in the X-linked PAK3 gene is the underlying cause of intellectual disability and macrocephaly in monozygotic twins.
    Hertecant J; Komara M; Nagi A; Al-Zaabi O; Fathallah W; Cui H; Yang Y; Eng CM; Al Sorkhy M; Ghattas MA; Al-Gazali L; Ali BR
    Eur J Med Genet; 2017 Apr; 60(4):212-216. PubMed ID: 28126652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential implication of the mental retardation proteins ARHGEF6 and PAK3 in spine morphogenesis.
    Nodé-Langlois R; Muller D; Boda B
    J Cell Sci; 2006 Dec; 119(Pt 23):4986-93. PubMed ID: 17105769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of p21-activated kinases 1 and 3 is altered in the brain of subjects with depression.
    Fuchsova B; Alvarez Juliá A; Rizavi HS; Frasch AC; Pandey GN
    Neuroscience; 2016 Oct; 333():331-44. PubMed ID: 27474226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAK3 is a key signature gene of the glioma proneural subtype and affects its proliferation, differentiation and growth.
    Magne N; Rousseau V; Duarte K; Poëa-Guyon S; Gleize V; Mutel A; Schmitt C; Castel H; Idbaih A; Huillard E; Sanson M; Barnier JV
    Cell Oncol (Dordr); 2021 Dec; 44(6):1257-1271. PubMed ID: 34550532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A GIT1/PIX/Rac/PAK signaling module regulates spine morphogenesis and synapse formation through MLC.
    Zhang H; Webb DJ; Asmussen H; Niu S; Horwitz AF
    J Neurosci; 2005 Mar; 25(13):3379-88. PubMed ID: 15800193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new constitutively active brain PAK3 isoform displays modified specificities toward Rac and Cdc42 GTPases.
    Rousseau V; Goupille O; Morin N; Barnier JV
    J Biol Chem; 2003 Feb; 278(6):3912-20. PubMed ID: 12464619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel
    Iida A; Takano K; Takeshita E; Abe-Hatano C; Hirabayashi S; Inaba Y; Kosugi S; Kamatani Y; Momozawa Y; Kubo M; Nakagawa E; Inoue K; Goto YI
    Cold Spring Harb Mol Case Stud; 2019 Dec; 5(6):. PubMed ID: 31444167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional analysis of rare variants found in schizophrenia implicates a critical role for GIT1-PAK3 signaling in neuroplasticity.
    Kim MJ; Biag J; Fass DM; Lewis MC; Zhang Q; Fleishman M; Gangwar SP; Machius M; Fromer M; Purcell SM; McCarroll SA; Rudenko G; Premont RT; Scolnick EM; Haggarty SJ
    Mol Psychiatry; 2017 Mar; 22(3):417-429. PubMed ID: 27457813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The intellectual disability PAK3 R67C mutation impacts cognitive functions and adult hippocampal neurogenesis.
    Castillon C; Gonzalez L; Domenichini F; Guyon S; Da Silva K; Durand C; Lestaevel P; Vaillend C; Laroche S; Barnier JV; Poirier R
    Hum Mol Genet; 2020 Jul; 29(12):1950-1968. PubMed ID: 31943058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De novo variants in PAK1 lead to intellectual disability with macrocephaly and seizures.
    Horn S; Au M; Basel-Salmon L; Bayrak-Toydemir P; Chapin A; Cohen L; Elting MW; Graham JM; Gonzaga-Jauregui C; Konen O; Holzer M; Lemke J; Miller CE; Rey LK; Wolf NI; Weiss MM; Waisfisz Q; Mirzaa GM; Wieczorek D; Sticht H; Abou Jamra R
    Brain; 2019 Nov; 142(11):3351-3359. PubMed ID: 31504246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.